A review of isotretinoin in the treatment of frontal fibrosing alopecia
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Amirhossein Shahpar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Research Center, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Isotretinoin, Alopecia, Dermatologic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Frontal fibrosing alopecia (FFA) is characterized by scarring alopecia of the frontotemporal scalp and facial papules. Isotretinoin is a vitamin A‐derived retinoid discovered in 1955 and approved for treating nodulocystic acne. This drug can also affect facial papules and frontotemporal hair loss in patients with FFA. In this article, we conducted a review of the available studies investigating the use of oral isotretinoin for FFA treatment. Our study provides insights into the efficacy and safety of isotretinoin as a potential treatment option for FFA and highlights areas for future research.
Method
In this study, we aimed to investigate the potential advantages and disadvantages of isotretinoin as a treatment for FFA. To identify all relevant articles, we developed a comprehensive search strategy and conducted a thorough search of three major databases: PubMed, Embase, and Science Direct. We retrieved a total of 82 articles from the search results. Two independent reviewers then screened each of the 82 articles based on our inclusion and exclusion criteria, resulting in the identification of 15 articles that were deemed relevant to our study.
Results
Across the 15 articles, 232 patients who suffered from FFA were involved. Nearly 90% of patients experienced a significant reduction of symptoms after receiving oral isotretinoin at 10–40 mg daily. We conclude that isotretinoin can positively affect facial papules and help suppress hair loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Research Center, Kerman University of Medical Sciences, Kerman, Iran.
- Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Dermatology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Department of Dermatology, Bushehr University of Medical Sciences, Bushehr, Iran.
- Pathology and Stem Cell Research Center, Bushehr University of Medical Sciences, Bushehr, Iran.
ORCID-Profile: Nazanin Zeinali Nezhad, Najmeh Ahramiyanpour
Zitieren
APA
Shahpar, A., Nezhad, N. Z., Sahaf, A. S., & Ahramiyanpour, N. (2024). A review of isotretinoin in the treatment of frontal fibrosing alopecia. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16245
Vancouver
Shahpar A, Nezhad NZ, Sahaf AS, Ahramiyanpour N. A review of isotretinoin in the treatment of frontal fibrosing alopecia. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16245
BibTeX
@article{Shahpar2024,
author = {Shahpar, Amirhossein and Nezhad, Nazanin Zeinali and Sahaf, Akram-Sadat and Ahramiyanpour, Najmeh},
title = {A review of isotretinoin in the treatment of frontal fibrosing alopecia},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16245}
}
EUVIMED